Brandes Investment Partners’s Elanco Animal Health ELAN Stock Holding History

Brandes Investment Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.5M	Sell	2,778,908 -1,422,956	-34%	-$34.8M	0.47%	76
2025 Q4	$95.1M	Sell	4,201,864 -1,737,653	-29%	-$37.8M	0.72%	47
2025 Q3	$120M	Sell	5,939,517 -2,160,805	-27%	-$36.2M	0.96%	40
2025 Q2	$116M	Buy	8,100,322 +820,901	+11%	+$9.59M	1.05%	37
2025 Q1	$76.4M	Buy	7,279,421 +1,548,241	+27%	+$17.5M	0.78%	45
2024 Q4	$69.4M	Buy	5,731,180 +2,296,691	+67%	+$30.1M	0.78%	45
2024 Q3	$50.5M	Buy	3,434,489 +488,522	+17%	+$6.81M	0.57%	60
2024 Q2	$42.4M	Buy	2,945,967 +36,944	+1%	+$590K	0.52%	64
2024 Q1	$47.4M	Sell	2,909,023 -658,791	-18%	-$10.3M	0.61%	55
2023 Q4	$53.2M	Buy	3,567,814 +116,222	+3%	+$1.32M	0.81%	45
2023 Q3	$38.8M	Buy	3,451,592 +538,797	+18%	+$6.26M	0.76%	46
2023 Q2	$29.3M	Buy	2,912,795 +851,823	+41%	+$7.91M	0.59%	52
2023 Q1	$19.4M	Buy	2,060,972 +1,892,639	+1,124%	+$22.3M	0.41%	65
2022 Q4	$2.06M	Buy	168,333 +26,907	+19%	+$335K	0.06%	91
2022 Q3	$1.76M	Buy	+141,426	New	+$2.47M	0.05%	125

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Brandes Investment Partners's ELAN Position: Q1 2026 in Review

Brandes Investment Partners reduced its Elanco Animal Health (ELAN) stake by 34% in Q1 2026, selling an estimated $34.8M and leaving 2,778,908 shares worth $66.5M. The position accounts for 0.47% of the portfolio, ranked #76.

Brandes Investment Partners first reported a position in ELAN in Q3 2022 and has held it in 15 quarters since. The position peaked at $120M in Q3 2025. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Brandes Investment Partners held 2,778,908 shares of Elanco Animal Health worth $66.5M as of Q1 2026.
Brandes Investment Partners sold 1,422,956 Elanco Animal Health shares in Q1 2026, an estimated $34.8M.
Elanco Animal Health made up 0.47% of Brandes Investment Partners's portfolio in Q1 2026, its #76 holding.
Brandes Investment Partners first reported a position in Elanco Animal Health in Q3 2022 and has held it in 15 quarters since.
Brandes Investment Partners's Elanco Animal Health position peaked at $120M in Q3 2025.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.